Review of the Rationale for Strategic Shareholdings and Reduction of Holdings
First written in FY2019. 2 of 8 entries say "Restated". Latest entry: FY2026.
22 other companies' latest entry also says "Other".
- FY2026Update on Cross-ShareholdingsAnnual report
「Following a review by the Board of Directors in April 2026, the company confirmed that holding all issues was appropriate.」
For cross-shareholdings, the company confirmed at the April 2026 Board of Directors meeting that holding all issues remained appropriate. Listed shares totaled 12 issues worth ¥624 million, and 2 unlisted issues were sold. - FY2025Update on Cross-ShareholdingsAnnual report
「Following a review by the Board of Directors in April 2025, the company confirmed that holding all issues was appropriate.」
For cross-shareholdings, the company confirmed at the April 2025 Board of Directors meeting that holding all issues remained appropriate. The company held 12 listed issues worth ¥478 million, and disclosed additional purchases of 4 issues worth ¥9 million and the sale of 1 unlisted issue worth ¥10 million. - FY2024RestatedAnnual report
「Following a review by the Board of Directors in April 2024, the company confirmed that holding all issues was appropriate.」
For cross-shareholdings, the company continued its monthly reviews of share price trends and annual reviews of the appropriateness of holdings, confirming at the April 2024 Board of Directors meeting that holding all issues was appropriate. - FY2021RestatedAnnual report
「In addition, for each individual cross-shareholding, the Board of Directors verifies share price trends every month. Once a year, the Board also reviews the appropriateness of holding each individual issue based on factors including the issue's operating performance, dividend amount, dividend yield and trading status. Following a review by the Board of Directors in May 2021, the company confirmed that holding all issues was appropriate.」
The company continued its monthly reviews of share price trends and annual reviews of the appropriateness of holdings, confirming at the May 2021 Board of Directors meeting that holding all issues was appropriate. - FY2020ReframedAnnual report
「In addition, for each individual cross-shareholding, the Board of Directors verifies share price trends every month. Once a year, the Board also reviews the appropriateness of holding each individual issue based on factors including the issue's operating performance, dividend amount, dividend yield and trading status. Following a review by the Board of Directors in May 2020, the company confirmed that holding all issues was appropriate.」
The explanation has shifted from the reduction of cross-shareholdings explicitly stated in the previous fiscal year to a focus on monthly and annual reviews by the Board of Directors and confirmation that holding all issues remains appropriate. - FY2020-Q2Additional impairment loss on investment securities recognizedAnnual report
「Valuation loss on investment securities 18,252」
The company recognized a valuation loss on investment securities of ¥18.252 million as an extraordinary loss during the cumulative consolidated second quarter period. No change to the policy of reviewing and reducing cross-shareholdings was stated. - FY2020-Q1Recognition of impairment losses on shares heldAnnual report
「The company recognized disaster relief subsidies of ¥105.770 million as extraordinary income and impairment losses of ¥22.807 million on shares held as an extraordinary loss.」
Impairment losses of ¥22.807 million on shares held were recognized as an extraordinary loss. No change to the policy of reviewing and reducing cross-shareholdings was stated. - FY2019First statedAnnual report
「In addition, for each individual cross-shareholding, the Board of Directors verifies the holding every fiscal year. For shares whose rationale for holding has weakened, we will work to reduce cross-shareholdings while engaging in dialogue and negotiations with business partners.」
The company newly stated a policy of reviewing cross-shareholdings annually at Board of Directors meetings and reducing holdings whose rationale has weakened.